ACRS Aclaris Therapeutics, Inc.
$5.32▼ -3.36%
Healthcare
Other
Volume 3.28M
Avg Volume (10D) 2.13M
Key Metrics & Fundamentals
Market Cap
$783.10M
P/E Ratio
–
Div Yield
–%
52W Range
1.74 - 6.60
% vs 50 MA
-8.14%
% vs 200 MA
24.39%
RSI-14
37.1
MACD Histogram
-0.1200
Beta (1Y vs SPY)
0.65
Free Cash Flow
-$19.91M
Gross Rev
$1.63M
Gross Profit
$176,000
EBITDA
-$23.53M
COGS
$1.45M
Operating Exp
$24.11M
Operating Income
-$23.94M
EBIT
-$23.94M
Pretax Income
-$21.51M
Net Income
-$21.51M
EPS (Diluted)
-0.15
Price & Volume History
Loading chart…
Recent News
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
GlobeNewswire · Sep 3, 2026 12:00 PM
Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target
MT Newswires · Sep 1, 2026 10:45 AM
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade
Zacks · Aug 10, 2026 1:55 PM
Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP)
GlobeNewswire · Aug 6, 2026 8:35 PM
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 6, 2026 12:20 PM
Aclaris: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 11:18 AM
Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update
GlobeNewswire · Aug 6, 2026 10:59 AM
Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength?
Zacks · Jul 1, 2026 12:23 PM
3 Penny Stocks Under $5 Backed by Real Revenue Growth
MarketBeat · Jun 20, 2026 1:20 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ACRS's money flow as a full page
Social Sentiment
No Reddit posts found for ACRS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.